Syncona Ltd

We found, build and fund companies to translate exceptional science into transformational treatments for patients in areas of high unmet need





Platinum Sponsor & Exhibitor

ATMPS Ltd has created the Hataali platform which digitises the end to end, cell and gene therapy process, providing immutable digital records with full chain of custody, identity and condition data. It can be used for clinical trials and commercially available therapies.

Hataali allows clinics, pharmaceutical companies, and couriers to communicate and coordinate their activities in real time. Hataali is modular and interoperable, integrating existing systems. It is patented and future-proof utilising blockchain technology.

Hospitals can digitally enrol and screen patients and order multiple treatments from multiple pharmaceutical companies through a single portal.

Pharmaceutical companies can easily administer, monitor and schedule treatments to multiple clinics in multiple countries, over one platform. Our digital analytics dashboards provide data driven decision making capabilities.

The Hataali platform significantly reduces implementation times and costs to users of the cell and gene therapy ecosystem. It increases efficiency, ensures patient safety and provides regulatory compliance.



BIO is the world’s largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations.  BIO’s members develop medical products and technologies to treat patients afflicted with serious diseases, to delay the onset of these diseases, or to prevent them in the first place


London Advanced Therapies


King’s College London



LifeArc is a leading UK medical research charity that transforms promising life science ideas into medical breakthroughs that change patients’ lives. We specialise in early-stage translation – advancing lab-based scientific discoveries to a point at which they can be developed into the next generation of diagnostics, treatments and cures. LifeArc partner and work with academics, industry, charities and patient groups to unlock the potential of early-stage science. We do this by providing three types of support: translational advice (business and industrial know-how), translational science (our own lab-based research), and translational funding (investments and philanthropic grants). Through our new strategy, making life science life changing, we plan to spend up to £1.3 billion by 2030, to help patient-focused life sciences to flourish.



From innovation to commercialisation: CPI acts as a catalyst bringing together academia, businesses, government and investors to translate bright ideas and research into the marketplace. We do this by giving our customers access to the right experts, equipment, networks, funding and more – connecting the dots for effective innovation.

We are a leading independent technology innovation centre and a founding member of the UK Government’s High Value Manufacturing Catapult. Established in 2004, our teams tirelessly apply their many years of experience to ensure that every great invention gets the best opportunity to become a successfully marketed product or process. We work with our partners across diverse markets in the UK and around the world, driving their innovations forward and helping them to reduce the risk and cost associated with product development.